These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

178 related articles for article (PubMed ID: 38017409)

  • 1. Identification and characterization of ARID1A-interacting proteins in renal tubular cells and their molecular regulation of angiogenesis.
    Yoodee S; Peerapen P; Plumworasawat S; Malaitad T; Thongboonkerd V
    J Transl Med; 2023 Nov; 21(1):862. PubMed ID: 38017409
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Somsuan K; Peerapen P; Boonmark W; Plumworasawat S; Samol R; Sakulsak N; Thongboonkerd V
    FASEB J; 2019 Nov; 33(11):12226-12239. PubMed ID: 31424966
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mir-144-3p Promotes Cell Proliferation, Metastasis, Sunitinib Resistance in Clear Cell Renal Cell Carcinoma by Downregulating ARID1A.
    Xiao W; Lou N; Ruan H; Bao L; Xiong Z; Yuan C; Tong J; Xu G; Zhou Y; Qu Y; Hu W; Gao Y; Ru Z; Liu L; Xiao H; Chen K; Yang H; Zhang X
    Cell Physiol Biochem; 2017; 43(6):2420-2433. PubMed ID: 29073615
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ARID1A knockdown in human endothelial cells directly induces angiogenesis by regulating angiopoietin-2 secretion and endothelial cell activity.
    Yoodee S; Peerapen P; Plumworasawat S; Thongboonkerd V
    Int J Biol Macromol; 2021 Jun; 180():1-13. PubMed ID: 33675830
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased expression of the ARID1A gene is associated with poor prognosis in primary gastric cancer.
    Wang DD; Chen YB; Pan K; Wang W; Chen SP; Chen JG; Zhao JJ; Lv L; Pan QZ; Li YQ; Wang QJ; Huang LX; Ke ML; He J; Xia JC
    PLoS One; 2012; 7(7):e40364. PubMed ID: 22808142
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Arid1a regulates response to anti-angiogenic therapy in advanced hepatocellular carcinoma.
    Hu C; Li W; Tian F; Jiang K; Liu X; Cen J; He Q; Qiu Z; Kienast Y; Wang Z; Zhang H; Ji Y; Hu J; Hui L
    J Hepatol; 2018 Mar; 68(3):465-475. PubMed ID: 29113912
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Endothelial Arid1a deletion disrupts the balance among angiogenesis, neurogenesis and gliogenesis in the developing brain.
    Wang Y; Su L; Wang W; Zhao J; Wang Y; Li S; Liu Y; Chai R; Li X; Teng Z; Liu C; Hu B; Ji F; Jiao J
    Cell Prolif; 2023 May; 56(5):e13447. PubMed ID: 36916004
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ARID1A regulates E-cadherin expression in colorectal cancer cells: a promising candidate therapeutic target.
    Erfani M; Zamani M; Hosseini SY; Mostafavi-Pour Z; Shafiee SM; Saeidnia M; Mokarram P
    Mol Biol Rep; 2021 Oct; 48(10):6749-6756. PubMed ID: 34424445
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Knockdown of mutated ARID1A inhibited endometrial cancer cell proliferation and stimulated cell apoptosis.
    Ye Y; Wei B; Xiaowei X
    J BUON; 2018; 23(4):1082-1091. PubMed ID: 30358215
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased expression of ARID1A associates with poor prognosis and promotes metastases of hepatocellular carcinoma.
    He F; Li J; Xu J; Zhang S; Xu Y; Zhao W; Yin Z; Wang X
    J Exp Clin Cancer Res; 2015 May; 34(1):47. PubMed ID: 25975202
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Functional analysis of in-frame indel ARID1A mutations reveals new regulatory mechanisms of its tumor suppressor functions.
    Guan B; Gao M; Wu CH; Wang TL; Shih IeM
    Neoplasia; 2012 Oct; 14(10):986-93. PubMed ID: 23097632
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Remodeling of the ARID1A tumor suppressor.
    Luo Q; Wu X; Liu Z
    Cancer Lett; 2020 Oct; 491():1-10. PubMed ID: 32738271
    [TBL] [Abstract][Full Text] [Related]  

  • 13. METTL8 mRNA Methyltransferase Enhances Cancer Cell Migration via Direct Binding to ARID1A.
    Lee SA; Lee KH; Kim H; Cho JY
    Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34063990
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Reduced expression of the chromatin remodeling gene ARID1A enhances gastric cancer cell migration and invasion via downregulation of E-cadherin transcription.
    Yan HB; Wang XF; Zhang Q; Tang ZQ; Jiang YH; Fan HZ; Sun YH; Yang PY; Liu F
    Carcinogenesis; 2014 Apr; 35(4):867-76. PubMed ID: 24293408
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mass spectrometric analysis of the phosphorylation levels of the SWI/SNF chromatin remodeling/tumor suppressor proteins ARID1A and Brg1 in ovarian clear cell adenocarcinoma cell lines.
    Kimura A; Arakawa N; Hirano H
    J Proteome Res; 2014 Nov; 13(11):4959-69. PubMed ID: 25083560
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Identification of a novel GR-ARID1a-P53BP1 protein complex involved in DNA damage repair and cell cycle regulation.
    Stubbs FE; Flynn BP; Rivers CA; Birnie MT; Herman A; Swinstead EE; Baek S; Fang H; Temple J; Carroll JS; Hager GL; Lightman SL; Conway-Campbell BL
    Oncogene; 2022 Dec; 41(50):5347-5360. PubMed ID: 36344675
    [TBL] [Abstract][Full Text] [Related]  

  • 17. ARID1B is a specific vulnerability in ARID1A-mutant cancers.
    Helming KC; Wang X; Wilson BG; Vazquez F; Haswell JR; Manchester HE; Kim Y; Kryukov GV; Ghandi M; Aguirre AJ; Jagani Z; Wang Z; Garraway LA; Hahn WC; Roberts CW
    Nat Med; 2014 Mar; 20(3):251-4. PubMed ID: 24562383
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ARID1A, a factor that promotes formation of SWI/SNF-mediated chromatin remodeling, is a tumor suppressor in gynecologic cancers.
    Guan B; Wang TL; Shih IeM
    Cancer Res; 2011 Nov; 71(21):6718-27. PubMed ID: 21900401
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Virus-host interactions in carcinogenesis of Epstein-Barr virus-associated gastric carcinoma: Potential roles of lost ARID1A expression in its early stage.
    Abe H; Kunita A; Otake Y; Kanda T; Kaneda A; Ushiku T; Fukayama M
    PLoS One; 2021; 16(9):e0256440. PubMed ID: 34469459
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Implication of ARID1A Undercurrents and PDL1, TP53 Overexpression in Advanced Gastric Cancer.
    Qadir J; Majid S; Khan MS; Rashid F; Wani MD; Bhat SA
    Pathol Oncol Res; 2021; 27():1609826. PubMed ID: 34924820
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.